Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group
- PMID:9425228
- DOI: 10.1093/hmg/7.2.209
Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group
Erratum in
- Hum Mol Genet 1998 May;7(5):941
Abstract
Germline mutations in the p16 and CDK4 genes have been reported in a subset of melanoma pedigrees, but their prevalence is not well known. We searched for such germline mutations in 48 French melanoma-prone families selected according to two major criteria: families with at least three affected members (n = 20) or families with two affected members, one of them affected before the age of 50 (n = 28), and one additional minor criterion. Sixteen different p16 germline mutations were found in 21 families, while one germline mutation, Arg24His, was detected in the CDK4 gene. The frequency of p16 gene mutation in our sample (44%) is among the highest rates yet reported and the CDK4 mutation is the second mutation detected in this gene worldwide. In summary, our results show frequent involvement of the p16 gene in familial melanoma and confirm the role of the CDK4 gene as a melanoma-predisposing gene.
Similar articles
- CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.Della Torre G, Pasini B, Frigerio S, Donghi R, Rovini D, Delia D, Peters G, Huot TJ, Bianchi-Scarra G, Lantieri F, Rodolfo M, Parmiani G, Pierotti MA.Della Torre G, et al.Br J Cancer. 2001 Sep 14;85(6):836-44. doi: 10.1054/bjoc.2001.1991.Br J Cancer. 2001.PMID:11556834Free PMC article.
- p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression.Piccinin S, Doglioni C, Maestro R, Vukosavljevic T, Gasparotto D, D'Orazi C, Boiocchi M.Piccinin S, et al.Int J Cancer. 1997 Feb 20;74(1):26-30. doi: 10.1002/(sici)1097-0215(19970220)74:1<26::aid-ijc5>3.0.co;2-2.Int J Cancer. 1997.PMID:9036865
- Rarity of CDK4 germline mutations in familial melanoma.Goldstein AM, Chidambaram A, Halpern A, Holly EA, Guerry IV D, Sagebiel R, Elder DE, Tucker MA.Goldstein AM, et al.Melanoma Res. 2002 Feb;12(1):51-5. doi: 10.1097/00008390-200202000-00008.Melanoma Res. 2002.PMID:11828258
- The genetics of hereditary melanoma and nevi. 1998 update.Greene MH.Greene MH.Cancer. 1999 Dec 1;86(11 Suppl):2464-77. doi: 10.1002/(sici)1097-0142(19991201)86:11+<2464::aid-cncr3>3.0.co;2-f.Cancer. 1999.PMID:10630172Review.
- Genes involved in melanoma: an overview of INK4a and other loci.Castellano M, Parmiani G.Castellano M, et al.Melanoma Res. 1999 Oct;9(5):421-32.Melanoma Res. 1999.PMID:10596908Review.
Cited by
- POLE mutations in families predisposed to cutaneous melanoma.Aoude LG, Heitzer E, Johansson P, Gartside M, Wadt K, Pritchard AL, Palmer JM, Symmons J, Gerdes AM, Montgomery GW, Martin NG, Tomlinson I, Kearsey S, Hayward NK.Aoude LG, et al.Fam Cancer. 2015 Dec;14(4):621-8. doi: 10.1007/s10689-015-9826-8.Fam Cancer. 2015.PMID:26251183
- Melanoma genetics and the development of rational therapeutics.Chudnovsky Y, Khavari PA, Adams AE.Chudnovsky Y, et al.J Clin Invest. 2005 Apr;115(4):813-24. doi: 10.1172/JCI24808.J Clin Invest. 2005.PMID:15841168Free PMC article.Review.
- Novel Biomarkers and Druggable Targets in Advanced Melanoma.Ferrucci PF, Cocorocchio E.Ferrucci PF, et al.Cancers (Basel). 2021 Dec 24;14(1):81. doi: 10.3390/cancers14010081.Cancers (Basel). 2021.PMID:35008245Free PMC article.Review.
- Mutation screening of CHD5 in melanoma-prone families linked to 1p36 revealed no deleterious coding or splice site changes.Ng D, Yang XR, Tucker MA, Goldstein AM.Ng D, et al.BMC Res Notes. 2008 Sep 19;1:86. doi: 10.1186/1756-0500-1-86.BMC Res Notes. 2008.PMID:18803848Free PMC article.
- Targeting human melanoma neoantigens by T cell receptor gene therapy.Leisegang M, Kammertoens T, Uckert W, Blankenstein T.Leisegang M, et al.J Clin Invest. 2016 Mar 1;126(3):854-8. doi: 10.1172/JCI83465. Epub 2016 Jan 25.J Clin Invest. 2016.PMID:26808500Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases